Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo

This study has been completed.

Study NCT00515229 Information provided by University Hospital Tuebingen

First Received: August 9, 2007 Last Updated: August 10, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	July 2007
Estimated Primary Completion Date:	No date given

No publications provided by University Hospital Tuebingen

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Becker KA, Riethmüller J, Lüth A, Döring G, Kleuser B, Gulbins E. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am J Respir Cell Mol Biol. 2010 Jun;42(6):716-24. Epub 2009 Jul 27.